Investigate the effects of synbiotic supplement containing Bacillus coagulans and inulin in the treatment of non-alcoholic fatty liver

Not Applicable

Completed

• Conditions: non alcoholic fatty liver disease.; K75.8; Other spec

• Registration Number: IRCT20100524004010N23
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 21 May 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Inclusion Criteria for the study: Age >18 years old; Fill out the form consent and approve it; Controlled Attenuation Parameter (CAP score)>263; Having a history of alcohol consumption less than 10 mg per day in women and less than 20 mg per day in men; Absence of other acute and chronic diseases and disorders of the liver (hepatitis B, C, etc.), biliary disease, known autoimmune diseases, cancer and inherited disorders affecting liver condition (storage disease of iron, and copper. ..); Absence of Hypertension, cardio - vascular diseases, lung disease and kidney disease, cirrhosis and celiac disease; Absence of pregnancy or lactation, athletes or hospitalization; Not consume medications such as metformin, vitamin E and Ursodeoxycholic Acid (UDCA); Not consume hepatotoxic drugs such as phenytoin, tamoxifen and lithium and corticosteroids and methotrexate; Not consume medications of antibiotics over a week during the study period or before entering it; No history of weight loss surgery in the past year the 3-month weight loss program; No history of hypothyroidism, Cushing's syndrome and diabetes , lack of gall bladder disease. Exclusion Criteria for the study: Food intolerance and unlikely side effects from taking supplements; pregnancy..

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified